A Strategy for Defining Biologically Relevant Levels of p53 Protein Expression in Clinical Samples with Reference to Endometrial Neoplasia
W. Glenn McCluggage(Belfast Health and Social Care Trust), Peter A. Hall, Paula L. Hyland(Queen's University Belfast), G. McGregor(University Hospitals Coventry and Warwickshire NHS Trust), L E Connolly(Anna Needs Neuroblastoma Answers)
International Journal of Gynecological Pathology
September 13, 2005
Cited by 60
Related Papers
The p53 pathway
|The Journal of Pathology|1999|1.3k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Boosted decision trees as an alternative to artificial neural networks for particle identification
|Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment|2005|535
First measurement of the muon neutrino charged current quasielastic double differential cross section
|Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology|2010|410